
Investment Stage: Series A; Series B
Portfolio 43
Date | Name | Website | Total Raised | Location |
11.04.2025 | OneBeat | onebeat.co | $15M | - |
11.04.2025 | Ottometric | ottometric.com | $14.9M | United Sta... |
29.07.2024 | Mantle Inc... | mantle3d.com | $45M | United Sta... |
29.07.2024 | Brixton Bi... | brixtonbio.com | $33M | United Sta... |
27.10.2023 | Amplified ... | amplified.industries | $10M | United Sta... |
27.10.2023 | Capital Pr... | capitalprovisions.com | - | United Sta... |
31.05.2023 | Meili | meili.travel | - | Ireland, L... |
31.05.2023 | Congruity3... | congruity360.com | - | United Sta... |
31.05.2023 | MediaSilo | mediasilo.com | $2.25M | United Sta... |
31.05.2023 | Carecubes | carecubes.com | - | Jamaica, S... |
Show more
Mentions in press and media 21
Date | Title | Description |
13.05.2025 | Remedy Plan Therapeutics Raises $18M Financing | Remedy Plan Therapeutics, a Gaithersburg, MD-based clinical-stage pharmaceutical company developing new, hyperbolic NAMPT inhibitors, raised $18M in funding. Backers included Schooner Capital, Alexandria Venture Investments, and other exist... |
19.07.2024 | Mantle: Metal 3D Printing Company Raises $20 Million | Mantle, a leader in metal 3D printing technology for precision tooling, announced it has reached a significant milestone by securing $20 million in Series C funding. This funding round brought the total to over $61.5 million and it also mar... |
13.07.2024 | Mantle Secures $20 Million in Series C Funding to Transform Tooling Industry | In a groundbreaking move, Mantle, a San Francisco-based company specializing in metal 3D printing technology, has successfully raised $20 million in its latest Series C funding round. This significant investment, led by Boston-based private... |
12.07.2024 | Mantle announces $20M funding round | Register now for our Additive Manufacturing Advantage online event for insights on AM developments in aerospace, space, and defense sectors from industry leaders! Metal 3D printer manufacturer Mantle has raised $20 million in its latest Ser... |
16.05.2024 | Brixton Biosciences: Leading the Charge in Pain Management Innovation | Brixton Biosciences, a cutting-edge clinical-stage life sciences company, has recently secured a substantial $33 million in Series B funding to propel their groundbreaking work in advancing novel pain therapies. Spearheaded by the visionary... |
14.05.2024 | Brixton Biosciences Secures $33M to Advance Novel Pain Therapies | Sameer Sabir, Chief Executive Officer of Brixton Biosciences What You Should Know: – Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital w... |
10.08.2020 | Prpotech start-up Breezeway raises USD 8M to help property managers | US-Boston based, Breezeway, a property operations and services platform has raised USD 8M funding in series A on 5th August, 2020. The funds will be utilized to support property managers cross those jobs off their list. |
19.10.2016 | 4G Clinical Raises $5m in Series A1 Financing | 4G Clinical, a Wellesley, MA-based clinical trials software company, raised $5m in Series A1 financing. The round was led by Boston-based Schooner Capital. The company, which has raised $7.5m in total funding, intends to use the capital to ... |
19.10.2016 | 4G Clinical Raises $5 Million Series A1 Financing Led By Schooner Capital | 4G Clinical, a clinical trials software company focused on simplifying and accelerating the drug development process, said today that it has raised $5 million in Series A1 financing led by Boston-based Schooner Capital. Combined with $2.5 m... |
21.03.2016 | Maxwell Health closes $22M Series C to move it towards 10 million user goal | The fundraise follows a $26.4 million Series B round dating back to December 2014. At that time it had 68 staff. It currently employs 150, according to Xconomy. In addition to helping employees understand and manage their health insurance a... |
Show more